Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Clinical trial NCT07631637 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07631637
- Sponsor
- Regeneron Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2029-02-06
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.